LS Investment Advisors LLC Raises Stake in Zeltiq Aesthetics Inc (ZLTQ)

LS Investment Advisors LLC raised its position in shares of Zeltiq Aesthetics Inc (NASDAQ:ZLTQ) by 187.2% during the first quarter, according to its most recent filing with the SEC. The institutional investor owned 4,369 shares of the medical equipment provider’s stock after buying an additional 2,848 shares during the period. LS Investment Advisors LLC’s holdings in Zeltiq Aesthetics were worth $243,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of ZLTQ. Comerica Bank boosted its stake in Zeltiq Aesthetics by 5.1% in the first quarter. Comerica Bank now owns 40,215 shares of the medical equipment provider’s stock worth $2,271,000 after buying an additional 1,958 shares during the last quarter. BNP Paribas Arbitrage SA boosted its stake in Zeltiq Aesthetics by 17.8% in the first quarter. BNP Paribas Arbitrage SA now owns 7,495 shares of the medical equipment provider’s stock worth $417,000 after buying an additional 1,131 shares during the last quarter. Suntrust Banks Inc. boosted its stake in Zeltiq Aesthetics by 1.8% in the first quarter. Suntrust Banks Inc. now owns 5,682 shares of the medical equipment provider’s stock worth $315,000 after buying an additional 101 shares during the last quarter. Bank of New York Mellon Corp boosted its stake in shares of Zeltiq Aesthetics by 20.2% in the first quarter. Bank of New York Mellon Corp now owns 619,048 shares of the medical equipment provider’s stock valued at $34,426,000 after buying an additional 103,922 shares in the last quarter. Finally, US Bancorp DE boosted its stake in shares of Zeltiq Aesthetics by 4.9% in the first quarter. US Bancorp DE now owns 24,316 shares of the medical equipment provider’s stock valued at $1,352,000 after buying an additional 1,145 shares in the last quarter.

Institutional Ownership by Quarter for Zeltiq Aesthetics (NASDAQ:ZLTQ)

Shares of Zeltiq Aesthetics Inc (ZLTQ) remained flat at $56.48 during trading on Friday. The firm’s 50 day moving average price is $56.05 and its 200 day moving average price is $46.95. Zeltiq Aesthetics Inc has a 12-month low of $23.58 and a 12-month high of $56.50.

TRADEMARK VIOLATION WARNING: This piece of content was reported by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this piece of content on another publication, it was stolen and republished in violation of U.S. and international trademark and copyright laws. The correct version of this piece of content can be viewed at https://www.chaffeybreeze.com/2017/06/17/ls-investment-advisors-llc-buys-2848-shares-of-zeltiq-aesthetics-inc-zltq-updated-updated.html.

Several analysts have weighed in on the stock. Canaccord Genuity reaffirmed a “hold” rating and set a $56.50 price objective on shares of Zeltiq Aesthetics in a research note on Tuesday, February 21st. Stifel Nicolaus lowered shares of Zeltiq Aesthetics from a “buy” rating to a “hold” rating in a research report on Thursday, March 2nd. Zacks Investment Research upgraded shares of Zeltiq Aesthetics from a “sell” rating to a “hold” rating in a research report on Wednesday, February 22nd. Finally, Aegis reiterated a “hold” rating and set a $56.00 target price on shares of Zeltiq Aesthetics in a research report on Monday, April 24th. Nine investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $50.94.

About Zeltiq Aesthetics

ZELTIQ Aesthetics, Inc is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. The Company’s product, the CoolSculpting System, is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists and obstetrics and gynecology (OBGYN) physicians.

Receive News & Ratings for Zeltiq Aesthetics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zeltiq Aesthetics Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply